Resultats globals: 1 registres trobats en 0.02 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
13 p, 1.6 MB Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus / Freemantle, Nick (University College London) ; Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ; Giaccari, Andrea (Università Cattolica del Sacro Cuore) ; Bailey, Timothy (AMCR Institute) ; Roussel, Ronan (UFR de Médecine. Paris University) ; Franco, Denise (CPCLIN Clinical Research Center) ; Berthou, Baptiste (IT&M Stats) ; Pilorget, Valerie (Sanofi) ; Westerbacka, Jukka (Sanofi) ; Bosnyak, Zsolt (Sanofi) ; Bonnemaire, Mireille (Sanofi) ; Cali, Anna M.G (Sanofi) ; Nguyên-Pascal, My-Liên (Sanofi) ; Penfornis, Alfred (Corbeil-Essonnes and Université Paris Sud) ; Perez-Maraver, Manuel (Hospital Universitari de Bellvitge) ; Seufert, Jochen (University of Freiburg) ; Sullivan, Sean D. (University of Washington) ; Wilding, John (University of Liverpool) ; Wysham, Carol (Multicare Rockwood Clinic) ; Davies, Melanie (University of Leicester) ; Universitat Autònoma de Barcelona
To compare real-world outcomes with newer (insulin glargine 300 U/mL; Gla-300) versus standard of care (SoC) basal insulins (BIs) in the REACH (insulin-naïve; NCT02967224) and REGAIN (basal insulin-treated; NCT02967211) studies in participants with uncontrolled type 2 diabetes (T2DM) in Europe and Brazil. [...]
2020 - 10.1080/03007995.2019.1708287
Current Medical Research and Opinion, Vol. 36 Núm. 4 (february 2020) , p. 571-581  

Vegeu també: autors amb noms similars
1 Bosnyak, Zsolt
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.